Meijuan Huang Selected Research

Meijuan Huang Research Topics

Disease

34	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2010
27	Neoplasms (Cancer) 03/2024 - 04/2005
11	Adenocarcinoma of Lung 02/2024 - 07/2014
10	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2017
6	Disease Progression 11/2022 - 08/2013
5	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2016
5	Colonic Neoplasms (Colon Cancer) 07/2023 - 01/2011
5	Hemorrhage 03/2023 - 01/2017
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2023 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2020 - 07/2009
3	Infections 02/2024 - 02/2017
3	Hemophilia A (Haemophilia) 01/2023 - 12/2019
3	Lung Neoplasms (Lung Cancer) 04/2020 - 07/2014
2	Melanoma (Melanoma, Malignant) 03/2024 - 01/2019
2	Hemolysis 02/2024 - 01/2013
2	Lymphoma (Lymphomas) 02/2024 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 07/2017
2	Inflammation (Inflammations) 12/2022 - 01/2018
2	Hand-Foot Syndrome 01/2022 - 01/2020
2	Diarrhea 02/2021 - 08/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Esophageal Squamous Cell Carcinoma 01/2020 - 09/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 11/2012
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2016 - 10/2015
2	Leukemia 02/2015 - 04/2005
1	Necrosis 03/2024
1	Malignant Pleural Effusion 02/2024
1	Malignant Mesothelioma 02/2024
1	Exanthema (Rash) 04/2023
1	Hemophilia B (Haemophilia B) 01/2023

Drug/Important Bio-Agent (IBA)

13	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2015
12	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
12	ErbB Receptors (EGF Receptor)IBA 04/2024 - 05/2005
5	Pemetrexed (MTA)FDA Link 01/2023 - 07/2014
4	Inosine Triphosphate (ITP)IBA 12/2023 - 01/2017
4	CytokinesIBA 01/2023 - 01/2017
4	Phosphotransferases (Kinase)IBA 01/2022 - 07/2014
4	Anaplastic Lymphoma KinaseIBA 12/2021 - 07/2014
4	CrizotinibIBA 09/2020 - 07/2014
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2018
3	ceritinibIBA 04/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2019 - 07/2009
2	Bevacizumab (Avastin)FDA Link 02/2024 - 04/2018
2	Ceruloplasmin (Ferroxidase)IBA 07/2023 - 01/2016
2	anlotinibIBA 04/2023 - 01/2022
2	rezivertinibIBA 01/2023 - 11/2022
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2021
2	Peptides (Polypeptides)IBA 12/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 12/2022 - 01/2021
2	osimertinibIBA 06/2022 - 01/2021
2	eltrombopag FDA Link 01/2022 - 01/2017
2	PlatinumIBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 02/2018
2	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 12/2019
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2020
2	AntigensIBA 01/2020 - 04/2005
2	nasIBA 10/2019 - 01/2019
2	ProdrugsIBA 10/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2016
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018 - 11/2012
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2015 - 01/2013
2	MicellesIBA 01/2013 - 11/2012
1	lyseninIBA 03/2024
1	AminesIBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	isoxanthohumolIBA 02/2024
1	Vancomycin FDA LinkGeneric 02/2024
1	AsbestosIBA 02/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024
1	ThiazolesIBA 01/2024
1	C-Reactive ProteinIBA 12/2023
1	thrombopoietin mimetic peptideIBA 12/2023
1	romiplostim FDA Link 12/2023
1	Biosimilar PharmaceuticalsIBA 12/2023
1	sintilimabIBA 10/2023
1	human ERBB2 proteinIBA 04/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2023
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2023
1	LigandsIBA 01/2023
1	SmokeIBA 01/2023
1	SolutionsIBA 12/2022
1	sym-trinitrobenzeneIBA 12/2022
1	EnrofloxacinIBA 12/2022
1	Sulfonic AcidsIBA 12/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022
1	GlucocorticoidsIBA 11/2022
1	pralsetinibIBA 06/2022
1	MethyltransferasesIBA 01/2022

Therapy/Procedure

28	Therapeutics 03/2024 - 01/2011
10	Drug Therapy (Chemotherapy) 02/2024 - 06/2012
9	Immunotherapy 04/2024 - 01/2020
9	Radiotherapy 12/2023 - 06/2012
3	Chemoradiotherapy 01/2020 - 06/2010
2	Esophagectomy 01/2020 - 06/2012
2	Transplantation 01/2016 - 10/2015
2	Salvage Therapy 06/2012 - 01/2012
1	Oral Administration 12/2022